Status:
COMPLETED
Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Lipid Metabolism Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Gather additional efficacy and safety (pharmacovigilance) information in the usual daily care in patients with Dyslipidemia on ezetimibe under real conditions in Colombia associated with statins.
Eligibility Criteria
Inclusion
- \> 18 years old
- Lipid Metabolic Disorder as Per ATP III who have not reached the goals and who are on statins for at least 4 weeks Or those who require LDL reductions Over 50% to reach the ATP III goals or who need statins in accordance their risk score
Exclusion
- Pregnancy, Breast Feeding
- Moderate/Sever Liver Disease: Child Score \> Or = To 7
- Fibrates Terminal Disease
- Contraindications To Receive ezetimibe
- Contraindications To Receive Statins
- Mental Disability
- Hypersensitivity To ezetimibe
- On another Clinical Research Trial
Key Trial Info
Start Date :
September 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2005
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00651963
Start Date
September 1 2004
End Date
March 1 2005
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.